Completed
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
NCT00035100
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +22 more
- Locations
-
- Novartis Investigative Site New Brunswick, New Jersey, United States
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Enschede, Netherlands
- Novartis Investigative Site Amsterdam, Netherlands